HIV INTEGRASE SH3 INTERACTIONS

HIV 整合酶 SH3 相互作用

• 批准号: 7722234
• 负责人: MARK AYER MUESING
• 金额: $ 0.41万
• 依托单位: ROCKEFELLER UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-03-01 至 2009-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7722234
• 关键词: Cells; Computer Retrieval of Information on Scientific Projects Database; DNA; Endopeptidases; Enzymes; Funding; Genes; Grant; HIV; HIV Integrase; Immune system; Infection; Institution; Integrase; Peptide Hydrolases; RNA-Directed DNA Polymerase; Research; Research Personnel; Resources; Source; Therapeutic; United States National Institutes of Health; Virus

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. HIV integrase is the virus's third enzyme (the other two are reverse transcriptase and protease). HIV uses integrase to incorporate its genes into a host cell's DNA. Inhibition of HIV integrase is an attractive therapeutic strategy since it would potentially protect healthy cells from infection thereby helping to bolster the immune system. We are currently investigating integrase SH3 interactions.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 HIV整合酶是病毒的第三个酶（其他两种是逆转录酶和蛋白酶）。 HIV使用整合酶将其基因掺入宿主细胞的DNA中。 抑制HIV整合酶是一种有吸引力的治疗策略，因为它可能会保护健康细胞免受感染，从而有助于增强免疫系统。 我们目前正在研究集成酶SH3相互作用。